UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Acoustic metamaterial for low frequency sound absorption in linear and nonlinear regimes

Journal of sound and vibration, 2020-10, Vol.485, p.115585, Article 115585

2020

Volltextzugriff (PDF)

A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)

Breast cancer research and treatment, 2021-11, Vol.190 (2), p.265-275

2021

Volltextzugriff (PDF)

Phase II trial of eribulin in patients who do not achieve pathologic complete response (pCR) following neoadjuvant chemotherapy

Breast cancer research and treatment, 2020-04, Vol.180 (3), p.647-655

2020

Volltextzugriff (PDF)

Use of a multiplexed immunoassay (PRO Onc assay) to detect HER2 abnormalities in circulating tumor cells of women with HER2-negative metastatic breast cancer: lack of response to HER2-targeted therapy

Breast cancer research and treatment, 2016-11, Vol.160 (1), p.41-49

2016

Volltextzugriff (PDF)

Insights into the Spectrum of Activity and Mechanism of Action of MGB-BP‑3

ACS infectious diseases, 2022-12, Vol.8 (12), p.2552-2563

2022

Volltextzugriff (PDF)

TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer

Breast cancer research and treatment, 2017-08, Vol.164 (3), p.649-658

2017

Volltextzugriff (PDF)

Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial

Clinical breast cancer, 2016-10, Vol.16 (5), p.349-355

2016

Volltextzugriff (PDF)

Correction: Truncated S-MGBs: towards a parasite-specific and low aggregation chemotype

RSC medicinal chemistry, 2021-12, Vol.12 (12), p.271-271

2021

Volltextzugriff (PDF)

Truncated S-MGBs: towards a parasite-specific and low aggregation chemotype

RSC medicinal chemistry, 2021-08, Vol.12 (8), p.1391-141

2021

Volltextzugriff (PDF)

Control of Zootechnology Leads to Improved Cuttlefish (Sepia officinalis, L.) Reproduction Performance up to Pre-industrial Levels

Frontiers in Marine Science, 2020-02, Vol.7

2020

Volltextzugriff (PDF)

Multiple resonances in lossy acoustic black holes - theory and experiment

Journal of sound and vibration, 2023-01, Vol.543, p.117377, Article 117377

2023

Volltextzugriff (PDF)

Addition of bevacizumab to three docetaxel regimens as adjuvant therapy for early stage breast cancer

Breast cancer research and treatment, 2013-12, Vol.142 (3), p.655-665

2013

Volltextzugriff (PDF)

Advancing the Care of Women With HER2-Positive Metastatic Breast Cancer

Journal of the advanced practitioner in oncology, 2023-04, Vol.14 (3), p.248-251

2023

Volltextzugriff (PDF)

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

The New England journal of medicine, 2021-04, Vol.384 (16), p.1529-1541

2021

Volltextzugriff (PDF)

Abstract P1-18-35: Futibatinib in combination with fulvestrant in patients with metastatic breast cancer (MBC) harboring high-level FGFR1 amplification: Preliminary data from a phase 2 study

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P1-P1-18-35

2022

Volltextzugriff (PDF)

Phase II trial of eribulin in patients who do not achieve pathologic complete response

Breast cancer research and treatment, 2020-04, Vol.180 (3), p.647

2020

Volltextzugriff (PDF)

Saci-IO TNBC: Randomized phase II trial of sacituzumab govitecan (SG) +/- pembrolizumab in PD-L1– metastatic triple-negative breast cancer (mTNBC)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS1106-TPS1106

2021

Volltextzugriff (PDF)

Abstract PD13-07: Subgroup analysis of patients with brain metastases from the phase 3 ASCENT study of sacituzumab govitecan versus chemotherapy in metastatic triple-negative breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PD13-07-PD13-07

2021

Volltextzugriff (PDF)

Acoustic Metamaterials Comprised of Dead-End Pores and Black Hole Effect for Low Frequency Sound Absorption in Linear and Nonlinear Regimes

Brooke, Daniel Craig

2021

Volltextzugriff (PDF)

Retinoic Acid Receptor-β2 Promoter Methylation in Random Periareolar Fine Needle Aspiration

Cancer epidemiology, biomarkers & prevention, 2005-04, Vol.14 (4), p.790-798

2005

Volltextzugriff (PDF)

The design and use of a simple System Suitability Test Mix for generic reverse phase high performance liquid chromatography–mass spectrometry systems and the implications for automated system monitoring using global software tracking

Journal of Chromatography A, 2011-06, Vol.1218 (23), p.3711-3717

2011

Volltextzugriff (PDF)

Use of a multiplexed immunoassay

Breast cancer research and treatment, 2016-11, Vol.160 (1), p.41

2016

Volltextzugriff (PDF)

Abstract RF01-04: Final results from the phase 2, open-label FOENIX-MBC2 study: efficacy and safety of futibatinib in adult patients with locally advanced/metastatic HR+/HER2− breast cancer harboring high-level FGFR1 gene amplification

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.RF01-04-RF01-04

2024

Volltextzugriff (PDF)

Identifying and interpreting actionable molecular alterations from next-generation sequencing results in the community: A Sarah Cannon molecular cancer conference

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.6601-6601

2018

Volltextzugriff (PDF)

Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study

Clinical breast cancer, 2016-12, Vol.16 (6), p.471-479.e1

2016

Volltextzugriff (PDF)

1 – 25 von 1.315

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.129)
Mit Volltextzugriff
(1.075)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(792)
Life Sciences & Biomedicine
(658)
Humans
(476)
Female
(260)
Male
(206)
Adult
(152)
Middle Aged
(133)
Animals
(109)
Social Sciences
(104)
Biological And Medical Sciences
(100)
Aged
(97)
Oncology
(85)
Medical Sciences
(82)
Adolescent
(73)
Science & Technology - Other Topics
(71)
Physical Sciences
(69)
Multidisciplinary Sciences
(66)
Public, Environmental & Occupational Health
(66)
Psychology
(63)
Risk Factors
(61)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(610)
MEDLINE
(559)
Ingenta
(474)
Journals@Ovid Ovid Full Text
(432)
NUS Single-Journal Subscriptions
(304)
IngentaConnect Journals
(212)
Elsevier ScienceDirect Journals
(204)
Wiley-Blackwell Journals
(141)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(116)
Springer journals
(95)
Wiley Online Library
(91)
JSTOR
(80)
Nexis Uni
(72)
Oxford Journals
(68)
Nature_系列刊
(61)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(57)
Ebook Central Perpetual and DDA
(51)
eBooks on EBSCOhost
(51)
Oxford Journals 2020 Medicine
(49)
Taylor & Francis
(48)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Music Week
(34)
Journal Of Clinical Oncology
(30)
Cancer Research
(21)
Plos One
(19)
Cancer Epidemiology, Biomarkers & Prevention
(16)
Chest
(16)
Critical Care Medicine
(11)
Nature
(11)
Nature Communications
(11)
Science
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Acoustic metamaterial for low frequency sound absorption in linear and nonlinear regimes

A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)

Phase II trial of eribulin in patients who do not achieve pathologic complete response (pCR) following neoadjuvant chemotherapy

Use of a multiplexed immunoassay (PRO Onc assay) to detect HER2 abnormalities in circulating tumor cells of women with HER2-negative metastatic breast cancer: lack of response to HER2-targeted therapy

Insights into the Spectrum of Activity and Mechanism of Action of MGB-BP‑3

TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer

Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial

Correction: Truncated S-MGBs: towards a parasite-specific and low aggregation chemotype

Truncated S-MGBs: towards a parasite-specific and low aggregation chemotype

Control of Zootechnology Leads to Improved Cuttlefish (Sepia officinalis, L.) Reproduction Performance up to Pre-industrial Levels

Multiple resonances in lossy acoustic black holes - theory and experiment

Addition of bevacizumab to three docetaxel regimens as adjuvant therapy for early stage breast cancer

Advancing the Care of Women With HER2-Positive Metastatic Breast Cancer

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

Abstract P1-18-35: Futibatinib in combination with fulvestrant in patients with metastatic breast cancer (MBC) harboring high-level FGFR1 amplification: Preliminary data from a phase 2 study

Phase II trial of eribulin in patients who do not achieve pathologic complete response

Saci-IO TNBC: Randomized phase II trial of sacituzumab govitecan (SG) +/- pembrolizumab in PD-L1– metastatic triple-negative breast cancer (mTNBC)

Abstract PD13-07: Subgroup analysis of patients with brain metastases from the phase 3 ASCENT study of sacituzumab govitecan versus chemotherapy in metastatic triple-negative breast cancer

Acoustic Metamaterials Comprised of Dead-End Pores and Black Hole Effect for Low Frequency Sound Absorption in Linear and Nonlinear Regimes

Retinoic Acid Receptor-β2 Promoter Methylation in Random Periareolar Fine Needle Aspiration

The design and use of a simple System Suitability Test Mix for generic reverse phase high performance liquid chromatography–mass spectrometry systems and the implications for automated system monitoring using global software tracking

Use of a multiplexed immunoassay

Abstract RF01-04: Final results from the phase 2, open-label FOENIX-MBC2 study: efficacy and safety of futibatinib in adult patients with locally advanced/metastatic HR+/HER2− breast cancer harboring high-level FGFR1 gene amplification

Identifying and interpreting actionable molecular alterations from next-generation sequencing results in the community: A Sarah Cannon molecular cancer conference

Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study

Suchergebnisse filtern